Oxygenta Pharmaceutical Limited (BOM:524636)
India · Delayed Price · Currency is INR 50.58
+0.58 (1.16%)
At close: Mar 5, 2026
Oxygenta Pharmaceutical Market Cap
Oxygenta Pharmaceutical has a market cap or net worth of 1.87 billion as of March 5, 2026. Its market cap has decreased by -43.47% in one year.
Market Cap
1.87B
Enterprise Value
2.59B
Revenue
1.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
50.58
Market Cap Chart
Since June 4, 1997, Oxygenta Pharmaceutical's market cap has increased from 7.22M to 1.87B, an increase of 25,820.82%. That is a compound annual growth rate of 21.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 1.87B | -9.34% |
| Dec 31, 2025 | 2.06B | -36.22% |
| Dec 31, 2024 | 3.23B | 210.06% |
| Dec 29, 2023 | 1.04B | 159.15% |
| Dec 30, 2022 | 402.61M | 2.53% |
| Dec 31, 2021 | 392.67M | 307.32% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gennex Laboratories | 2.67B |
| Kerala Ayurveda | 2.61B |
| Sat Kartar Life | 2.60B |
| Sanjivani Paranteral | 2.30B |
| BDH Industries | 2.24B |
| Ambalal Sarabhai Enterprises | 1.94B |
| Astonea Labs | 1.67B |
| Coral Laboratories | 1.53B |